Drupal.behaviors.print = function(context) {window.print();window.close();}>

Myriad Genetics Licenses Cancer Dx Technology from Chronix

May 10, 2011

Myriad Genetics Licenses Cancer Dx Technology from Chronix

Myriad has licensed the technology for early detection of breast, colon, and prostate cancers.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories